SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001157523-24-000013
Filing Date
2024-01-04
Accepted
2024-01-04 06:01:02
Documents
2
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 INNATE PHARMA S.A. 6-K a53876727.htm 6-K 8282
2 EXHIBIT 99.1 a53876727ex99_1.htm EX-99.1 13315
  Complete submission text file 0001157523-24-000013.txt   22769
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 24509685
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)